Celanese (CE) PT Raised to $130 at Citi

Barclays Reinstates Celanese (CE) at Overweight

Barclays reinstates coverage on Celanese (NYSE: CE) with a Overweight rating and a price target of $140.00.

Analyst Duffy Fischer says headwinds are turning into tailwinds and believes the current valuation is attractive while noting that the story is compelling despite the... More

Celanese Corp. (CE) Raises Quarterly Dividend 17.4% to $0.54; 1.9% Yield

Celanese Corp. (NYSE: CE) declared a quarterly dividend of $0.54 per share, or $2.16 annualized. This is a 17.4% increase from the prior dividend of $0.46.

The dividend will be payable on May 10, 2018, to stockholders of record on April 30, 2018, with an ex-dividend date of April 27, 2018.

The... More

Celanese (CE) PT Raised to $138 at Goldman Sachs Following 1Q

Goldman Sachs raised its price target on Celanese (NYSE: CE) to $138.00 (from $137.00) while maintaining a Buy rating following the company's 1Q earnings release. CE reported adjusted 1Q EPS of $2.79, meaningfully above the Street estimates of $2.33.

Goldman Sachs' updated estimates imply a 12% upside to the... More

Celanese (CE) PT Raised to $141 at KeyBanc

KeyBanc raised its price target on Celanese (NYSE: CE) to $141.00 (from $131.00) while maintaining a Overweight rating.

Celanese (CE) PT Raised to $128 at RBC Capital; 'Exceptionally Strong Quarter'

RBC Capital raised its price target on Celanese (NYSE: CE) to $128.00 (from $124.00) while maintaining a Outperform rating.

Analyst Arun Viswanathan notes the company delivered an "exceptionally strong quarter" on improvement in the upstream Acetyls Chain.

Celanese (CE) PT Raised to $111 at Nomura/Instinet

Nomura/Instinet raised its price target on Celanese (NYSE: CE) to $111.00 (from $105.00) while maintaining a Neutral rating.

Celanese (CE) PT Raised to $137 at BMO Capital

Analyst B. Lodaya says "The company has the potential to shock the Street based on tightening markets."

BMO Capital raised its price target on Celanese (NYSE: CE) to $137.00 (from $131.00) while maintaining a Outperform rating.